230 related articles for article (PubMed ID: 8063392)
1. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys.
Kwaga JK; Allan BJ; van der Hurk JV; Seida H; Potter AA
Infect Immun; 1994 Sep; 62(9):3766-72. PubMed ID: 8063392
[TBL] [Abstract][Full Text] [Related]
2. An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
Nagano T; Kitahara R; Nagai S
Microbiol Immunol; 2012 Sep; 56(9):605-12. PubMed ID: 22708916
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a live attenuated Escherichia coli O78:K80 vaccine in chickens and turkeys.
La Ragione RM; Woodward MJ; Kumar M; Rodenberg J; Fan H; Wales AD; Karaca K
Avian Dis; 2013 Jun; 57(2):273-9. PubMed ID: 24689185
[TBL] [Abstract][Full Text] [Related]
4. Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis.
Ebrahimi-Nik H; Bassami MR; Mohri M; Rad M; Khan MI
PLoS One; 2018; 13(3):e0194888. PubMed ID: 29566080
[TBL] [Abstract][Full Text] [Related]
5. Avian pathogenic Escherichia coli (APEC).
Dho-Moulin M; Fairbrother JM
Vet Res; 1999; 30(2-3):299-316. PubMed ID: 10367360
[TBL] [Abstract][Full Text] [Related]
6. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
[TBL] [Abstract][Full Text] [Related]
7. Construction, characterization, and evaluation of the vaccine potential of three genetically defined mutants of avian pathogenic Escherichia coli.
Kariyawasam S; Wilkie BN; Gyles CL
Avian Dis; 2004; 48(2):287-99. PubMed ID: 15283416
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Iss as a potential vaccine for avian colibacillosis.
Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
[TBL] [Abstract][Full Text] [Related]
9. Comparative pathologic findings of Escherichia coli infection in birds.
Cheville NF; Arp LH
J Am Vet Med Assoc; 1978 Sep; 173(5 Pt 2):584-7. PubMed ID: 359516
[TBL] [Abstract][Full Text] [Related]
10. Construction and evaluation of a delta cya delta crp Salmonella typhimurium strain expressing avian pathogenic Escherichia coli O78 LPS as a vaccine to prevent airsacculitis in chickens.
Roland K; Curtiss R; Sizemore D
Avian Dis; 1999; 43(3):429-41. PubMed ID: 10494411
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of an avian pathogenic Escherichia coli strain due to a mutation in the rpsL gene.
Amoako KK; Prysliak T; Potter AA; Collinson SK; Kay WW; Allan BJ
Avian Dis; 2004; 48(1):19-25. PubMed ID: 15077794
[TBL] [Abstract][Full Text] [Related]
12. Avian pathogenic Escherichia coli ΔtonB mutants are safe and protective live-attenuated vaccine candidates.
Holden KM; Browning GF; Noormohammadi AH; Markham P; Marenda MS
Vet Microbiol; 2014 Oct; 173(3-4):289-98. PubMed ID: 25205199
[TBL] [Abstract][Full Text] [Related]
13. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate.
Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X
Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598
[TBL] [Abstract][Full Text] [Related]
14. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers.
Peighambari SM; Hunter DB; Shewen PE; Gyles CL
Avian Dis; 2002; 46(2):287-97. PubMed ID: 12061637
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Escherichia coli isolated from cases of avian colibacillosis.
Allan BJ; van den Hurk JV; Potter AA
Can J Vet Res; 1993 Jul; 57(3):146-51. PubMed ID: 8358674
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of avian Escherichia coli cya crp mutants.
Peighambari SM; Gyles CL
Avian Dis; 1998; 42(4):698-710. PubMed ID: 9876838
[TBL] [Abstract][Full Text] [Related]
17. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli.
Melamed D; Leitner G; Heller ED
Avian Dis; 1991; 35(1):17-22. PubMed ID: 2029251
[TBL] [Abstract][Full Text] [Related]
18. Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts.
Dziva F; Stevens MP
Avian Pathol; 2008 Aug; 37(4):355-66. PubMed ID: 18622850
[TBL] [Abstract][Full Text] [Related]
19. Influence of vaccination of broiler chickens against Escherichia coli with live attenuated vaccine on general properties of E. coli population, IBV vaccination efficiency, and production parameters-a field experiment.
Śmiałek M; Kowalczyk J; Koncicki A
Poult Sci; 2020 Nov; 99(11):5452-5460. PubMed ID: 33142462
[TBL] [Abstract][Full Text] [Related]
20. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
